Instituto Universitario de Tecnologías Biomédicas
Institut d'investigació
Helsinki University Central Hospital
Helsinki, FinlandiaPublicacions en col·laboració amb investigadors/es de Helsinki University Central Hospital (8)
2024
-
Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching
Rheumatology (United Kingdom), Vol. 63, Núm. 7, pp. 1882-1892
-
Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network
Arthritis and Rheumatology, Vol. 76, Núm. 4, pp. 587-598
2023
-
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
The Lancet Regional Health - Europe, Vol. 33
-
Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia
Journal of Experimental Medicine, Vol. 220, Núm. 5
2022
-
Leveraging global multi-ancestry meta-analysis in the study of idiopathic pulmonary fibrosis genetics
Cell Genomics, Vol. 2, Núm. 10
2020
-
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
-
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Science, Vol. 370, Núm. 6515
2015
-
Scopolamine effects on functional brain connectivity: A pharmacological model of Alzheimer's disease
Scientific Reports, Vol. 5